TERM ID="NYU_TERM_1" STRING="HER2" FREQUENCY=3 START=0 END=4 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_2" STRING="HER2" FREQUENCY=3 START=478 END=482 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_3" STRING="HER2" FREQUENCY=3 START=1369 END=1373 LEMMA="HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="HER2 expression" FREQUENCY=1 START=892 END=907 LEMMA="HER2 EXPRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="HER2 immunogenicity" FREQUENCY=2 START=560 END=579 LEMMA="HER2 IMMUNOGENICITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_6" STRING="HER2 immunogenicity" FREQUENCY=2 START=695 END=714 LEMMA="HER2 IMMUNOGENICITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_7" STRING="HER2 status" FREQUENCY=1 START=994 END=1005 LEMMA="HER2 STATUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="HER2 testing" FREQUENCY=2 START=243 END=255 LEMMA="HER2 TESTING" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_9" STRING="HER2 testing" FREQUENCY=2 START=1074 END=1086 LEMMA="HER2 TESTING" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_10" STRING="HER2 tests" FREQUENCY=1 START=1109 END=1119 LEMMA="HER2 TEST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="absence" FREQUENCY=1 START=217 END=224 LEMMA="ABSENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="amplification" FREQUENCY=1 START=101 END=114 LEMMA="AMPLIFICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="epidermal growth factor receptor" FREQUENCY=1 START=124 END=156 LEMMA="EPIDERMAL GROWTH FACTOR RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="improvements" FREQUENCY=1 START=1024 END=1036 LEMMA="IMPROVEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="insensitive measurement" FREQUENCY=1 START=865 END=888 LEMMA="INSENSITIVE MEASUREMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="insensitive measurement of HER2 expression" FREQUENCY=1 START=865 END=907 LEMMA="HER2 EXPRESSION INSENSITIVE MEASUREMENT" LEMMA_FREQUENCY=1 HEAD_TERM="insensitive measurement" HEAD_LEMMA="INSENSITIVE MEASUREMENT"
TERM ID="NYU_TERM_17" STRING="nonspecific" FREQUENCY=1 START=850 END=861 LEMMA="NONSPECIFIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="oncologists" FREQUENCY=1 START=1297 END=1308 LEMMA="ONCOLOGIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="phosphatase" FREQUENCY=1 START=792 END=803 LEMMA="PHOSPHATASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="receptor expression" FREQUENCY=1 START=825 END=844 LEMMA="RECEPTOR EXPRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="tensin analog" FREQUENCY=1 START=808 END=821 LEMMA="TENSIN ANALOG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="therapeutic response" FREQUENCY=2 START=585 END=605 LEMMA="THERAPEUTIC RESPONSE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="therapeutic response" FREQUENCY=2 START=719 END=739 LEMMA="THERAPEUTIC RESPONSE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="trastuzumab" FREQUENCY=1 START=621 END=632 LEMMA="TRASTUZUMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="validation" FREQUENCY=1 START=1060 END=1070 LEMMA="VALIDATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="validation of HER2 testing" FREQUENCY=1 START=1060 END=1086 LEMMA="HER2 TESTING VALIDATION" LEMMA_FREQUENCY=1 HEAD_TERM="validation" HEAD_LEMMA="VALIDATION"
TERM ID="NYU_TERM_27" STRING="worse prognosis" FREQUENCY=1 START=194 END=209 LEMMA="WORSE PROGNOSIS" LEMMA_FREQUENCY=1
